Judge Says Impax, Apotex Infringed Prilosec Patents
Almost a year after the trial concluded in the long-standing dispute over AstraZeneca AB's patents for its gastric acid-inhibiting drug Prilosec, a federal judge ruled Thursday that the patents were valid...To view the full article, register now.
Already a subscriber? Click here to view full article